-
-
-
-
-
-
-
CorMedix Inc. Reports Second Quarter and Six Month 2022 Financial Results and Provides Business Update
-
-
-
-
-
-
-
CorMedix Inc. to Begin Trading on the Nasdaq Stock Exchange
-
-
-
-
-
-
-
CorMedix to Participate in BIO Investor Forum Digital
-
-
-
-
-
-
-
CorMedix Inc. Announces FDA Acceptance for Filing and Priority Review of New Drug Application for Defencath
14,982 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

